PET/MRI in patients with suspected prostate cancer PET/MRT bei Patienten mit Verdacht auf Prostatakarzinom

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-004758-33

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

We hypothesize that the image guided biopsy using multiparametric metabolic hybrid imaging with [18F]Fluoroethylcholine (FEC)/[68]Ga-PSMA-PET/MRI is superior in the detection of primary localized prostate cancer than the conventional biopsy approach with transrectal ultrasound in patients with suspected prostate cancer (according to the inclusion criteria) and could therefore significantly improve the detection rate of the dominant intraprostatic tumor lesion and reduce the number of biopsies needed for a correct histopathological diagnosis to a minimum in the future (PET/MRI guided biopsy).


Critère d'inclusion

  • Clinical suspected prostate cancer

Liens